BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27091687)

  • 21. Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination.
    Flaxman A; Yamaguchi Y; van Diemen PM; Rollier C; Allen E; Elshina E; Wyllie DH
    Vaccine; 2019 Jan; 37(3):494-501. PubMed ID: 30503080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
    Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
    Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.
    Sun H; Wei C; Liu B; Jing H; Feng Q; Tong Y; Yang Y; Yang L; Zuo Q; Zhang Y; Zou Q; Zeng H
    Int J Nanomedicine; 2015; 10():7275-90. PubMed ID: 26664118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
    Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
    Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
    Narita K; Hu DL; Asano K; Nakane A
    Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.
    Nissen M; Marshall H; Richmond P; Shakib S; Jiang Q; Cooper D; Rill D; Baber J; Eiden J; Gruber W; Jansen KU; Emini EA; Anderson AS; Zito ET; Girgenti D
    Vaccine; 2015 Apr; 33(15):1846-54. PubMed ID: 25707693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with a peptide mimicking Lipoteichoic acid protects mice against Staphylococcus aureus infection.
    Yi XY; Huang ZX; Hou XR; Zhu P; Wang XY; Luo HB; Liu BY
    Vaccine; 2019 Jul; 37(31):4325-4335. PubMed ID: 31230882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.
    Yang HJ; Zhang JY; Wei C; Yang LY; Zuo QF; Zhuang Y; Feng YJ; Srinivas S; Zeng H; Zou QM
    PLoS One; 2016; 11(2):e0149638. PubMed ID: 26895191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease.
    Elshina E; Allen ER; Flaxman A; van Diemen PM; Milicic A; Rollier CS; Yamaguchi Y; Wyllie DH
    Vaccine; 2019 Jan; 37(3):502-509. PubMed ID: 30502067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
    Pellegrino M; Giraudo J; Raspanti C; Nagel R; Odierno L; Primo V; Bogni C
    Vet Microbiol; 2008 Feb; 127(1-2):186-90. PubMed ID: 17869031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection.
    Rasmussen KJ; Mattsson AH; Pilely K; Asferg CA; Ciofu O; Vitved L; Koch C; Kemp M
    Vaccine; 2016 Aug; 34(38):4602-4609. PubMed ID: 27496278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective humoral and CD4
    Yu W; Yao D; Yu S; Wang X; Li X; Wang M; Liu S; Feng Z; Chen X; Li W; Wang L; Liu W; Ma J; Yu L; Tong C; Song B; Cui Y
    Sci Rep; 2018 Feb; 8(1):3580. PubMed ID: 29483570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
    Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
    Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montanide ISA 71 VG is Advantageous to Freund's Adjuvant in Immunization Against S. aureus Infection of Mice.
    Klimka A; Michels L; Glowalla E; Tosetti B; Krönke M; Krut O
    Scand J Immunol; 2015 May; 81(5):291-7. PubMed ID: 25689117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of ligand-binding domain of fibronectin-binding protein on mastitis induced by Staphylococcus aureus in mice.
    Hu C; Gong R; Guo A; Chen H
    Vaccine; 2010 May; 28(24):4038-44. PubMed ID: 20416265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.